4.4 Article

Effect of Weight Maintenance on Symptoms of Knee Osteoarthritis in Obese Patients: A Twelve-Month Randomized Controlled Trial 1

期刊

ARTHRITIS CARE & RESEARCH
卷 67, 期 5, 页码 640-650

出版社

WILEY
DOI: 10.1002/acr.22504

关键词

-

资金

  1. Oak Foundation
  2. Velux Foundation
  3. Cambridge Weight Plan (UK)
  4. Danish Rheumatism Association
  5. Augustinus Fonden
  6. A.P. Moller Foundation for the Advancement of Medical Science
  7. Aase og Ejnar Danielsens Fond
  8. Bjarne Jensens Fond
  9. Horslev Fonden
  10. Cambridge Manufacturing Company
  11. Opus
  12. New Nordic Diet
  13. Cambridge Weight Plan
  14. Servier
  15. Ossur
  16. Teijin
  17. AbbVie
  18. Medivir
  19. Flexion
  20. Arena Pharmaceuticals
  21. BioCare
  22. Boehringer Ingelheim Pharma
  23. Dutch Beer Knowledge Institute
  24. Gelesis
  25. Global Dairy Platform
  26. MacDonald's
  27. McCain Foods
  28. Novo Nordisk
  29. Orexigen Therapeutics
  30. Pathway Genomics
  31. Pfizer
  32. Psyadon Pharmaceuticals
  33. Rhythm Pharmaceuticals
  34. S-Biotek
  35. Twinlab
  36. Vivus

向作者/读者索取更多资源

Objective. To compare results of obese patients with knee osteoarthritis (OA) who, after an intensive weight loss regimen, received 1 year of either dietary support (D), a knee-exercise program (E), or no attention (C; control group). Methods. We conducted a randomized, 2-phase, parallel-group trial. A total of 192 obese participants with knee OA were enrolled; the mean age was 62.5 years and 81% were women with a mean entry weight of 103.2 kg. In phase 1, all participants were randomly assigned to 1 of 3 groups and began a dietary regimen of 400-810 and 1,250 kcal/day for 16 weeks (2 8-week phases) to achieve a major weight loss. Phase 2 consisted of 52 weeks' maintenance in either group D, E, or C. Outcomes were changes from randomization in pain on a 100-mm visual analog scale, weight, and response according to the Outcome Measures in Rheumatology-Osteoarthritis Research Society International criteria. Results. Mean weight loss for phase 1 was 12.8 kg. After 1 year on maintenance therapy, the D group sustained a lower weight (11.0 kg, 95% confidence interval [95% CI] 9.0, 12.8 kg) than those in the E (6.2, 95% CI 4.4, 8.1 kg) and C (8.2, 95% CI 6.4, 10.1 kg) groups (P = 0.002 by analysis of covariance [ANCOVA]). Adherence was low in the E group. All groups had statistically significant pain reduction (D: 6.1; E: 5.6; and C: 5.5 mm) with no difference between groups (P = 0.98 by ANCOVA). In each group 32 (50%), 26 (41%), and 33 (52%) participants responded to treatment in the D, E, and C groups, respectively, with no statistically significant difference in the number of responders (P = 0.41). Conclusion. A significant weight reduction with a 1-year maintenance program improves knee OA symptoms irrespective of maintenance program.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据